<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Common genetic variants in immune and <z:mp ids='MP_0001845'>inflammatory response</z:mp> genes can affect the risk of developing non-Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We aimed to test this hypothesis using previously unpublished data from eight European, Canadian, and US case-control studies of the International <z:hpo ids='HP_0002665'>Lymphoma</z:hpo> Epidemiology Consortium (InterLymph) </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: We selected 12 single-nucleotide polymorphisms for analysis, on the basis of previous functional or association data, in nine genes that have important roles in lymphoid development, Th1/Th2 balance, and proinflammatory or anti-inflammatory pathways (IL1A, IL1RN, IL1B, IL2, IL6, IL10, TNF, LTA, and CARD15) </plain></SENT>
<SENT sid="3" pm="."><plain>Genotype data for one or more single-nucleotide polymorphisms were available for 3586 cases of non-Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and for 4018 controls, and were assessed in a pooled analysis by use of a random-effects logistic regression model </plain></SENT>
<SENT sid="4" pm="."><plain>FINDINGS: The <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor (TNF) -308G--&gt;A polymorphism was associated with increased risk of non-Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (p for trend=0.005), particularly for diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, the main histological subtype (odds ratio 1.29 [95% CI 1.10-1.51] for GA and 1.65 [1.16-2.34] for AA, p for trend &lt;0.0001), but not for follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>The interleukin 10 (IL10) -3575T--&gt;A polymorphism was also associated with increased risk of non-Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (p for trend=0.02), again particularly for diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (p for trend=0.006) </plain></SENT>
<SENT sid="6" pm="."><plain>For individuals homozygous for the TNF -308A allele and carrying at least one IL10 -3575A allele, risk of diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> doubled (2.13 [1.37-3.32], p=0.00083) </plain></SENT>
<SENT sid="7" pm="."><plain>INTERPRETATION: Common polymorphisms in TNF and IL10, key cytokines for the <z:mp ids='MP_0001845'>inflammatory response</z:mp> and Th1/Th2 balance, could be susceptibility loci for non-Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>Moreover, our results underscore the importance of consortia for investigating the genetic basis of <z:hpo ids='HP_0011010'>chronic</z:hpo> diseases like <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
</text></document>